Study shows high efficacy rate for fecal transplants

04/13/2012 | Medscape (free registration)

Fecal transplants resolved recurrent Clostridium difficile infection in more than 90% of patients, according to a report in the American Journal of Gastroenterology. Montefiore Medical Center researchers said the study included long-term follow-up with patients who had followed an average of five unsuccessful courses of traditional treatments without success before having fecal transplantation. "FMT is a rational, durable, safe, and acceptable treatment option for patients with recurrent C. difficile infection," Dr. Lawrence J. Brandt and colleagues wrote.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD